Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vaccines|November 10, 2016
Is There Still Room for Cancer Vaccines at the Era of Checkpoint InhibitorsSoumaya Karaki, Marie Anson, Thi Tran, et al.
Frontiers in Immunology|August 14, 2018
Targeting Resident Memory T Cells for Cancer ImmunotherapyCharlotte Blanc, Sophie Hans, Thi Tran, et al.
Journal for Immunotherapy of Cancer|September 6, 2018
Resident memory T cells, critical components in tumor immunologyFathia Mami-Chouaib, Charlotte Blanc, Stéphanie Corgnac, et al.
ESMO Open|August 2, 2017
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancerClemence Granier, Eleonore De Guillebon, Charlotte Blanc, et al.
Medecine Sciences : M/S|March 17, 2018
[Tim-3: a novel biomarker and therapeutic target in oncology]Clémence Granier, Alain Gey, Charles Dariane, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2015
CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitisVirginie Desestret, Aude Chefdeville, Aurélien Viaccoz, et al.
Journal of Visualized Experiments : Jove|March 20, 2018
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T CellsClémence Granier, Emeline Vinatier, Elia Colin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 13, 2021
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 EncephalitisSergio Muñiz-Castrillo, Julie Haesebaert, Laure Thomas, et al.
Journal for Immunotherapy of Cancer|March 11, 2021
CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumorsSoumaya Karaki, Charlotte Blanc, Thi Tran, et al.
Nature Communications|May 25, 2017
Induction of resident memory T cells enhances the efficacy of cancer vaccineMevyn Nizard, Hélène Roussel, Mariana O Diniz, et al.
Pageof 1